Literature DB >> 19744724

Congenital toxoplasmosis in southeastern Brazil: results of early ophthalmologic examination of a large cohort of neonates.

Daniel Vitor Vasconcelos-Santos1, Danuza O Machado Azevedo, Wesley R Campos, Fernando Oréfice, Gláucia M Queiroz-Andrade, Ericka V Machado Carellos, Roberta M Castro Romanelli, José Nelio Januário, Luciana Macedo Resende, Olindo Assis Martins-Filho, Ana Carolina de Aguiar Vasconcelos Carneiro, Ricardo W Almeida Vitor, Waleska Teixeira Caiaffa.   

Abstract

OBJECTIVE: To report results of early ophthalmologic examinations in a large cohort of newborns with congenital toxoplasmosis (CT) after neonatal screening.
DESIGN: Cross-sectional analysis of a cohort. PARTICIPANTS: A total of 178 newborns with confirmed CT from 146,307 screened babies (95% of live births) from Minas Gerais state, southeastern Brazil.
METHODS: From November 2006 to May 2007, newborns underwent neonatal screening by immunoglobulin (Ig)M capture of dried blood samples. On all positive or suspected cases, confirmative serology was performed on babies and their mothers. Congenital toxoplasmosis was confirmed in newborns who had IgM and/or IgA and IgG, or IgG associated with suggestive ocular lesions (with IgM and IgG in the mother). Ophthalmologic evaluation consisted of indirect ophthalmoscopy with a lid speculum. Pediatric examination and radiologic studies of the central nervous system were also performed. In selected cases, biomicroscopy of the anterior segment, fundus photographs, or ultrasonography (B-scan) was performed. MAIN OUTCOME MEASURES: Prevalence of retinochoroidal lesions, either cicatricial or active, and their location and associated findings, such as vascular sheathing, hemorrhage, vitreous opacities, and retinal detachment, were evaluated. The occurrence of cataract, microphthalmia, microcephaly, intracranial calcification, and hydrocephalus was also recorded.
RESULTS: Of 146,307 neonates screened, 190 had CT, yielding a prevalence of 1 in 770 live births, of whom 178 (93.7%) underwent standardized ophthalmologic examination at an average age of 55.6+/-16.6 days. Of these 178 infants, 142 (79.8%) had retinochoroidal lesions consistent with CT in at least 1 eye. Bilateral involvement was noted in 113 patients (63.5%). Macular involvement was seen in 165 eyes (46.3%) of 111 patients (62.4%). Active lesions were observed in 142 eyes (39.9%) of 85 patients (47.8%). These lesions were located in the macula of 75 eyes (21.1%) and were associated with retinal vascular sheathing in 44 eyes (12.4%).
CONCLUSIONS: A high prevalence of CT was encountered (1/770) with high rates of early retinochoroidal involvement ( approximately 80%) and many active lesions (in approximately 50%), indicating a possibly more severe ocular involvement by CT in Brazil than in other parts of the world. The hypotheses of higher parasite virulence and increased individual susceptibility are being currently investigated.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19744724     DOI: 10.1016/j.ophtha.2009.04.042

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  30 in total

1.  A 31-year-old man with vitritis, chorioretinitis, and hydrocephalus.

Authors:  Andrew J Schneier
Journal:  Digit J Ophthalmol       Date:  2012-05-14

2.  Development of an in vitro system to study the developmental stages of Toxoplasma gondii using a genetically modified strain expressing markers for tachyzoites and bradyzoites.

Authors:  J A Portes; W De Souza
Journal:  Parasitol Res       Date:  2019-11-14       Impact factor: 2.289

Review 3.  The global burden of congenital toxoplasmosis: a systematic review.

Authors:  Paul R Torgerson; Pierpaolo Mastroiacovo
Journal:  Bull World Health Organ       Date:  2013-05-03       Impact factor: 9.408

4.  Typical Brazilian genotype of Toxoplasma gondii isolated from a horse destined for human consumption in Europe from a slaughterhouse.

Authors:  Hilda Fátima Jesus Pena; Thiago Mombach Pinheiro; Herbert Sousa Soares; Solange Oliveira; Bruna Farias Alves; Marina Neves Ferreira; Solange Maria Gennari
Journal:  Parasitol Res       Date:  2018-07-05       Impact factor: 2.289

Review 5.  Epidemiology of and diagnostic strategies for toxoplasmosis.

Authors:  Florence Robert-Gangneux; Marie-Laure Dardé
Journal:  Clin Microbiol Rev       Date:  2012-04       Impact factor: 26.132

Review 6.  Strain hypothesis of Toxoplasma gondii infection on the outcome of human diseases.

Authors:  J Xiao; R H Yolken
Journal:  Acta Physiol (Oxf)       Date:  2015-01-28       Impact factor: 6.311

Review 7.  Pediatric Cataract - Importance of Early Detection and Management.

Authors:  Sudarshan Khokhar; Ganesh Pillay; Esha Agarwal
Journal:  Indian J Pediatr       Date:  2017-11-09       Impact factor: 1.967

8.  Genetic characterization of Toxoplasma gondii revealed highly diverse genotypes for isolates from newborns with congenital toxoplasmosis in southeastern Brazil.

Authors:  Ana Carolina Aguiar Vasconcelos Carneiro; Gláucia Manzan Andrade; Júlia Gatti Ladeia Costa; Breno Veloso Pinheiro; Daniel Vitor Vasconcelos-Santos; Adriana Melo Ferreira; Chunlei Su; José Nélio Januário; Ricardo Wagner Almeida Vitor
Journal:  J Clin Microbiol       Date:  2013-01-02       Impact factor: 5.948

9.  Real-time PCR as a prognostic tool for human congenital toxoplasmosis.

Authors:  Júlia Gatti Ladeia Costa; Ana Carolina Aguiar Vasconcelos Carneiro; Alice Thomáz Tavares; Gláucia Manzan Queiroz Andrade; Daniel Vitor Vasconcelos-Santos; José Nélio Januário; Daniel Menezes-Souza; Ricardo Toshio Fujiwara; Ricardo Wagner Almeida Vitor
Journal:  J Clin Microbiol       Date:  2013-06-12       Impact factor: 5.948

10.  Hearing brain evaluated using near-infrared spectroscopy in congenital toxoplasmosis.

Authors:  Ana Lívia Libardi Bertachini; Gabriela Cintra Januario; Sergio Luiz Novi; Rickson Coelho Mesquita; Marco Aurélio Romano Silva; Gláucia Manzan Queiroz Andrade; Luciana Macedo de Resende; Débora Marques de Miranda
Journal:  Sci Rep       Date:  2021-05-12       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.